These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25042220)

  • 1. Towards a cure for HIV--are we making progress?
    Lewin SR; Deeks SG; Barré-Sinoussi F
    Lancet; 2014 Jul; 384(9939):209-11. PubMed ID: 25042220
    [No Abstract]   [Full Text] [Related]  

  • 2. An HIV cure: feasibility, discovery, and implementation.
    Fauci AS; Marston HD; Folkers GK
    JAMA; 2014 Jul 23-30; 312(4):335-6. PubMed ID: 25038345
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the significance of posttreatment control of HIV infection vis-à-vis functional cure?
    Vanham G; Buvé A; Florence E; Seguin-Devaux C; Sáez-Cirión A
    AIDS; 2014 Feb; 28(4):603-5. PubMed ID: 24401643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Towards eradication of human immunodeficiency virus (HIV)?].
    Katlama C
    Bull Acad Natl Med; 2013 Jun; 197(6):1177-85. PubMed ID: 25803930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV: Cure by killing.
    Richman DD
    Nature; 2015 Dec; 528(7581):198-9. PubMed ID: 26633623
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the glass three-quarters full or one-quarter empty?
    McArthur JC; Letendre SL
    J Infect Dis; 2006 Dec; 194(12):1628-31. PubMed ID: 17109332
    [No Abstract]   [Full Text] [Related]  

  • 7. Roundabout to remission.
    Dumiak M
    IAVI Rep; 2015; 19(2):4-8, 19. PubMed ID: 26233965
    [No Abstract]   [Full Text] [Related]  

  • 8. Reconsidering early HIV treatment and supervised treatment interruptions.
    Koup RA
    PLoS Med; 2004 Nov; 1(2):e41. PubMed ID: 15578109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS conference. Cure setbacks force HIV researchers to reset sights.
    Cohen J
    Science; 2014 Aug; 345(6196):495-6. PubMed ID: 25082673
    [No Abstract]   [Full Text] [Related]  

  • 10. The transient HIV remission in the Mississippi baby: why is this good news?
    Ananworanich J; Robb ML
    J Int AIDS Soc; 2014; 17(1):19859. PubMed ID: 25416415
    [No Abstract]   [Full Text] [Related]  

  • 11. Are antiretrovirals enough for people living with HIV?
    Phillips A; Baker J; Lundgren J
    Lancet; 2013 Nov; 382(9903):1466-7. PubMed ID: 24182530
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress on prevention and cure.
    Jefferys R
    IAVI Rep; 2014; 18(1):4-11. PubMed ID: 24933924
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment.
    Spagnuolo V; Cocorullo D; Galli L; Bigoloni A; Galli A; Rubinacci A; Mignogna G; Carbone A; Lazzarin A; Castagna A
    J Antimicrob Chemother; 2013 Dec; 68(12):2960-3. PubMed ID: 23812682
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV cure research: advances and prospects.
    Passaes CP; Sáez-Cirión A
    Virology; 2014 Apr; 454-455():340-52. PubMed ID: 24636252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hype and the HIV cure.
    McCartney M
    BMJ; 2013 Mar; 346():f1599. PubMed ID: 23479595
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues.
    Antonelli G
    Clin Microbiol Infect; 2010 Oct; 16(10):1509-10. PubMed ID: 20854461
    [No Abstract]   [Full Text] [Related]  

  • 17. T cell turnoff.
    Nogrady B
    Sci Am; 2007 Dec; 297(6):10-1. PubMed ID: 18237091
    [No Abstract]   [Full Text] [Related]  

  • 18. [Human immunodeficiency virus (HIV) type 1 with R5 tropism among HIV-1 antiretroviral-experienced patients in Spain].
    Arribas JR; Rivero A; Leal M; Sánchez-de la Rosa R
    Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):559-60. PubMed ID: 20400209
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings.
    Phillips AN; Pillay D; Garnett G; Bennett D; Vitoria M; Cambiano V; Lundgren J
    AIDS; 2011 Mar; 25(6):843-50. PubMed ID: 21192233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (ARV-) Free State? The moratorium's threat to patients' adherence and the development of drug-resistant HIV.
    El-Khatib Z; Richter M
    S Afr Med J; 2009 Jun; 99(6):412, 414. PubMed ID: 19739316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.